Thomas M. Hitchcock, Ph.D. is a formally trained scientist with expertise in molecular genetics, microbiology, and dermatology. He has more than twenty years of research experience, including basic science, proof-of-concept, pre-clinical and clinical research across several therapeutic areas such as cardiology, oncology, gene therapy, plastic/facial plastic surgery, microbiology, dermatology, and aesthetic medicine.
Dr. Hitchcock earned his PhD in Genetics from Clemson University where he studied DNA damage and repair in both prokaryotic and eukaryotic systems. After receiving his doctorate, he completed post-doctoral trainings at both Duke University and Yale University in Biomedical Engineering, Vascular Biology and Therapeutics, where he researched use of viral vectors in gene therapy techniques used to improve cardiovascular tissue engineering methodologies. Doctor Hitchcock concluded his academic training at Weil Cornell Medical College studying multiple myeloma genetics.
Following his post-doctoral studies, Dr. Hitchcock began working in the field of dermatology at the innovative startup Ulthera Inc. (acquired by Merz), as well as doing consultant work for pharmaceutical companies such as Boehringer Ingelheim and Bayer. In 2013, Dr. Hitchcock helped to found aesthetic device company Bellus Medical (now Crown Aesthetics) and served as the Acting Chief Scientific Officer until the acquisition by Crown Laboratories in 2018. He also Founded the skin microbiome technology company Xycrobe Therapeutics Inc. in 2014 and served as its Chief Executive Officer until acquisition by Crown in 2019. Dr. Hitchcock currently serves as the Chief Science Officer for Crown Laboratories. Additionally, Dr. Hitchcock serves as an Adjunct Faculty member at the East Tennessee State University James H. Quillen College of Medicine where he serves to collaborate with the faculty and students on research innovation; and he also serves on the Board of Directors for Microelastic Ultrasound Systems, a biotech, medical diagnostic system company.
Copyright © 2022 - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.